Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.
G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.
Pediatric Contact Lens Patients
February 28, 2008
Contact lenses: A winning option for you and young patients | ecp.acuvue.com
Contacts can successfully be worn with pediatric patinets as early as 10 years of age. With that being said, patient selection is crucial. You may encounter 10 year old patients that are as responsible as 7 year olds and vice versa.
BVT28949. A Possible Adjunct To Prostaglandin Analogs.
February 28, 2008
Biovitrum has Completed an Exploratory Clinical Phase II Study in Glaucoma | www.pipelinereview.com
Biovitrum may have discovered a new adjunct to our existing prostaglandin analogs. Currently, the prostaglandins generally lower patients pressures by 30-40% therefore making them first line therapy. If this new 5-HT2A drug can lower pressure an additional 10%, this drug would find a home in the glaucoma world.
Page : 11 to 2 of 2
February 7, 2012
What do the cloud, collaboration and virtualization have in common?
January 27, 2012
Clinical diagnostic acquisitions dominate 2011 top ten list
January 12, 2012
Gene therapy success threatens drugs for hemophilia and rare diseases
December 13, 2011
Medtech M&A activity accelerates in 2011
November 30, 2011